,0
0, https://www.fiercepharma.com/pharma/fierce-pharma-asia-eisais-subcutaneous-leqembi-study-astellas-ira-suit-gsks-taiwan-nucala
1, https://www.fiercepharma.com/pharma/top-line-podcast-why-pharma-needs-ramp-its-use-ai-and-machine-learning-tools-stay-ahead
2, https://www.fiercepharma.com/pharma/cell-and-gene-therapy-makers-push-past-regulatory-payer-hurdles-to-set-up-high-hopes-for
3, https://www.fiercepharma.com/manufacturing/cdmo-celonic-to-beef-up-cell-and-gene-therapy-at-swiss-novartis-hub
4, https://www.fiercepharma.com/manufacturing/emergent-plots-75m-expansion-to-produce-viral-vectors-for-expanding-gene-therapy
5, https://www.fiercepharma.com/pharma/now-cleared-for-launch-bluebird-aims-to-dose-first-zynteglo-patients-first-half
6, https://www.fiercepharma.com/pharma/gene-therapies-development-pfizer-brainstorming-payers-about-new-payment-models-bloomberg
7, https://www.fiercepharma.com/manufacturing/lonza-expanding-adc-production-as-pharma-business-thrives
8, https://www.fiercepharma.com/manufacturing/novartis-ready-to-meet-even-unprecedented-demand-for-zolgensma
9, https://www.fiercepharma.com/manufacturing/biotech-bought-gsk-s-bubble-boy-drug-to-build-stem-cell-manufacturing-facility-u-s
10, https://www.fiercepharma.com/pharma/spark-novartis-tie-up-gene-therapy-licensing-deal-worth-up-to-170m
11, https://www.fiercepharma.com/pharma/biogen-scrapping-sma-market-share-bets-10m-implant-improve-delivery-spinraza
12, https://www.fiercepharma.com/pharma/surge-raises-26m-take-anticancer-extended-release-hydrogel-clinic
13, https://www.fiercepharma.com/pharma/zealand-pumps-its-prospects-late-phase-rare-disease-hit
14, https://www.fiercepharma.com/drug-delivery/improving-immunotherapy-delivery-by-bringing-order-to-tumor-blood-vessels
15, https://www.fiercepharma.com/drug-delivery/gsk-puts-long-acting-injectables-at-heart-hiv-growth-plans-downplays-threat-oral
16, https://www.fiercepharma.com/drug-delivery/act-bags-cash-to-trial-local-iontophoresis-chemotherapy-delivery
17, https://www.fiercepharma.com/drug-delivery/urogen-s-rtgel-hopes-remain-high-after-botox-pairing-stumbles-overactive-bladder
18, https://www.fiercepharma.com/drug-delivery/recipharm-inks-205m-deal-india-s-kemwell-to-expand-reach
19, https://www.fiercepharma.com/manufacturing/more-growth-stevanato-italian-vials-maker-buys-plant-china
20, https://www.fiercepharma.com/pharma/roche-s-genentech-cleared-for-massive-headquarters-expansion-to-add-up-to-4-3m-square-feet]
